Year: 2015
Resolution Number: 6
Action Taken: Approved
Status:
Author(s): Karen Chapel, MD
Sponsor: Karen Chapel, MD
On behalf of:
Committee: A (Medical Care Delivery)
Resolved Section(s):
RESOLVED: That the American Medical Association work with interested parties including the United States Federal Trade Commission, United States Food and Drug Administration, generic drug companies, and United States Congress to explore the reasons behind increasing prices in generic drugs and possible remedies for the situation, as well as to track drug prices so that greater price transparency can help physicians prescribe lower cost drugs whenever reasonable alternatives are available.
RESOLVED: That the American Medical Association work with interested parties including the United States Federal Trade Commission, United States Food and Drug Administration, generic drug companies, and United States Congress to explore the reasons behind increasing prices in generic drugs and possible remedies for the situation, as well as to track drug prices so that greater price transparency can help physicians prescribe lower cost drugs whenever reasonable alternatives are available.
Fiscal Note: NULL
Resolution: View PDF for Rising Generic Drug Prices
For More Information, Contact: